AstraZeneca, Pfizer and Eli Lilly are among seven major pharmaceutical companies linking into a “ground-breaking” consortium striving to streamline an...
LONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca’s biggest new drug hope durvalumab as ...
London : GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 […]
Paris: Sanofi boosted its presence in cancer research by signing two deals with biotech companies worth up to $1.2 billion, […]
The U.S. Food and Drug Administration approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) […]
The European Medicines Agency said its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli […]
British drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more […]
French pharmaceutical company Sanofi and Britain’s AstraZeneca said they have agreed to share freely 210,000 proprietary chemical compounds as ...
U.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung […]
London: Britain’s AstraZeneca has said that it had agreed to buy U.S biotech company ZS Pharma for $2.7 billion, pipping Swiss […]